Published May 19, 2020 | Version v1
Journal article Open

Reversibility of Dilated Cardiomyopathy in a child with Sepsis

  • 1. Clinical and Interventional Paediatric Cardiologist, Registrar-Paediatric Cardiology, , Registrar- Paediatric Cardiology, Senior Consultant-Paediatrics, Evercare Hospital

Description

ABSTRACT

Dilated Cardiomyopathy is a diagnosis that usually carries a serious prognosis. However, among the numerous cases of dilated cardiomyopathy a few that are acute, fulminant and potentially reversible.

Sepsis induced cardiomyopathy is a reversible myocardial dysfunction that typically resolves in 7-10 days. It is characterized by left ventricular dilation and depressed ejection fraction.

Sepsis induced cardiomyopathy leads to a significant morbidity and mortality if not diagnosed early and treated judiciously with efficiency. Although the syndrome remains a dilemma along with conventional treatment of dilated cardiomyopathy, intensive fluid therapy, Ivabradine, trimetazidine dihydrochloride and above all aggressive source control and use of broad-spectrum antibiotics and maintenance of optimum hemodynamics with vasoactive agents. Our case study is reflecting that whenever an acute onset cardiomyopathy is found a reversible cause should be looked for.

Key words: Reversible Dilated Cardiomyopathy, Sepsis, Ivabradine, Trimetazidine dihydrochloride

Files

Dr. Tahera Nazrin-SJC.pdf

Files (358.5 kB)

Name Size Download all
md5:1c39d5e58c6ae3d8b90f0abeb747a0e7
358.5 kB Preview Download